Adverum Historical Income Statement

ADVM Stock  USD 14.66  0.51  3.60%   
Historical analysis of Adverum Biotechnologies income statement accounts such as Selling General Administrative of 31.8 M, Total Revenue of 2.8 M or Other Operating Expenses of 82 M can show how well Adverum Biotechnologies performed in making a profits. Evaluating Adverum Biotechnologies income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Adverum Biotechnologies's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Adverum Biotechnologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Adverum Biotechnologies is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.

About Adverum Income Statement Analysis

Adverum Biotechnologies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Adverum Biotechnologies shareholders. The income statement also shows Adverum investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Adverum Biotechnologies Income Statement Chart

Adverum Biotechnologies Income Statement is one of the three primary financial statements used for reporting Adverum's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Adverum Biotechnologies revenue and expense. Adverum Biotechnologies Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Adverum Biotechnologies' Depreciation And Amortization is very stable compared to the past year. As of the 28th of March 2024, Total Other Income Expense Net is likely to grow to about 5.8 M, though Interest Expense is likely to grow to (2.3 M).

Total Revenue

Total revenue comprises all receipts Adverum Biotechnologies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Adverum Biotechnologies. It is also known as Adverum Biotechnologies overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Adverum Biotechnologies' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Adverum Biotechnologies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.At this time, Adverum Biotechnologies' Depreciation And Amortization is very stable compared to the past year. As of the 28th of March 2024, Total Other Income Expense Net is likely to grow to about 5.8 M, though Interest Expense is likely to grow to (2.3 M).
 2021 2022 2023 2024 (projected)
Total Operating Expenses153.6M157.1M121.7M81.4M
Cost Of Revenue4.6M6.5M5.6M5.4M

Adverum Biotechnologies income statement Correlations

-0.60.890.74-0.60.91-0.92-0.930.91-0.93-0.210.9-0.910.19-0.91-0.02-0.92-0.010.150.310.910.550.55
-0.6-0.320.040.51-0.340.410.42-0.360.410.18-0.330.39-0.170.390.020.40.050.160.37-0.61-0.67-0.67
0.89-0.320.85-0.380.99-0.94-0.930.98-0.93-0.040.99-0.940.09-0.940.0-0.930.060.30.460.810.330.33
0.740.040.85-0.290.84-0.77-0.80.82-0.8-0.250.84-0.770.13-0.780.15-0.78-0.040.120.590.710.220.22
-0.60.51-0.38-0.29-0.430.410.51-0.470.50.45-0.430.41-0.250.41-0.250.460.150.12-0.38-0.7-0.28-0.28
0.91-0.340.990.84-0.43-0.94-0.951.0-0.94-0.021.0-0.940.13-0.94-0.03-0.930.030.330.460.830.330.33
-0.920.41-0.94-0.770.41-0.940.86-0.930.85-0.02-0.941.00.121.00.020.99-0.29-0.31-0.35-0.77-0.37-0.37
-0.930.42-0.93-0.80.51-0.950.86-0.951.00.12-0.950.85-0.410.850.040.840.25-0.28-0.44-0.84-0.4-0.4
0.91-0.360.980.82-0.471.0-0.93-0.95-0.950.01.0-0.930.15-0.93-0.05-0.920.00.350.460.830.320.32
-0.930.41-0.93-0.80.5-0.940.851.0-0.950.12-0.940.85-0.410.850.040.840.26-0.28-0.44-0.84-0.39-0.39
-0.210.18-0.04-0.250.45-0.02-0.020.120.00.12-0.01-0.01-0.230.0-0.530.110.240.8-0.1-0.49-0.25-0.25
0.9-0.330.990.84-0.431.0-0.94-0.951.0-0.94-0.01-0.940.12-0.94-0.03-0.930.030.330.480.820.310.31
-0.910.39-0.94-0.770.41-0.941.00.85-0.930.85-0.01-0.940.131.00.00.99-0.29-0.3-0.36-0.77-0.35-0.35
0.19-0.170.090.13-0.250.130.12-0.410.15-0.41-0.230.120.130.13-0.090.13-0.970.020.140.240.210.21
-0.910.39-0.94-0.780.41-0.941.00.85-0.930.850.0-0.941.00.130.00.99-0.29-0.3-0.37-0.77-0.35-0.35
-0.020.020.00.15-0.25-0.030.020.04-0.050.04-0.53-0.030.0-0.090.0-0.050.0-0.51-0.150.20.00.0
-0.920.4-0.93-0.780.46-0.930.990.84-0.920.840.11-0.930.990.130.99-0.05-0.29-0.22-0.37-0.81-0.35-0.35
-0.010.050.06-0.040.150.03-0.290.250.00.260.240.03-0.29-0.97-0.290.0-0.290.07-0.09-0.11-0.06-0.06
0.150.160.30.120.120.33-0.31-0.280.35-0.280.80.33-0.30.02-0.3-0.51-0.220.070.24-0.18-0.1-0.1
0.310.370.460.59-0.380.46-0.35-0.440.46-0.44-0.10.48-0.360.14-0.37-0.15-0.37-0.090.240.3-0.35-0.35
0.91-0.610.810.71-0.70.83-0.77-0.840.83-0.84-0.490.82-0.770.24-0.770.2-0.81-0.11-0.180.30.510.51
0.55-0.670.330.22-0.280.33-0.37-0.40.32-0.39-0.250.31-0.350.21-0.350.0-0.35-0.06-0.1-0.350.511.0
0.55-0.670.330.22-0.280.33-0.37-0.40.32-0.39-0.250.31-0.350.21-0.350.0-0.35-0.06-0.1-0.350.511.0
Click cells to compare fundamentals

Adverum Biotechnologies Account Relationship Matchups

Adverum Biotechnologies income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization1.6M4.2M4.6M6.5M5.6M5.9M
Selling General Administrative28.4M44.6M64.4M57.9M49.9M31.8M
Total Revenue1.6M250K7.5M3.6M4.1M2.8M
Gross Profit250K(4.2M)2.9M(6.5M)(2.0M)(1.9M)
Other Operating Expenses68.8M118.0M153.6M157.1M127.4M82.0M
Operating Income(68.5M)(118.0M)(146.1M)(157.1M)(123.8M)(130.0M)
Ebit(68.5M)(118.0M)(146.1M)(157.1M)(123.8M)(117.6M)
Research Development40.4M73.3M89.2M99.3M77.5M50.2M
Ebitda(67.0M)(113.8M)(141.5M)(150.6M)(118.1M)(112.2M)
Cost Of Revenue40.4M4.2M4.6M6.5M5.6M5.4M
Total Operating Expenses68.8M118.0M153.6M157.1M121.7M81.4M
Income Before Tax(64.5M)(116.4M)(145.5M)(154.5M)(118.2M)(124.2M)
Total Other Income Expense Net4.1M1.6M582K2.7M5.5M5.8M
Net Income(64.5M)(117.5M)(145.5M)(154.5M)(117.2M)(123.0M)
Income Tax Expense(4.1M)1.1M(582K)74K(1.1M)(1.1M)
Net Income From Continuing Ops(64.5M)(117.5M)(145.5M)(154.5M)(117.2M)(123.0M)
Non Operating Income Net Other4.4M4.1M1.7M154K177.1K168.2K
Net Income Applicable To Common Shares(64.5M)(117.5M)(145.5M)(154.5M)(139.1M)(146.0M)
Reconciled Depreciation1.6M4.2M4.6M6.5M5.6M4.1M

Pair Trading with Adverum Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adverum Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adverum Stock

  0.74EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Adverum Stock

  0.75VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.75CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.66MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.56MGTX MeiraGTx Holdings PLC Financial Report 9th of May 2024 PairCorr
  0.56PFE Pfizer Inc Fiscal Quarter End 31st of March 2024 PairCorr
The ability to find closely correlated positions to Adverum Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adverum Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adverum Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adverum Biotechnologies to buy it.
The correlation of Adverum Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adverum Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Adverum Stock analysis

When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.60)
Revenue Per Share
0.357
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.32)
Return On Equity
(0.88)
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.